Department of Medicine, Veterans Affairs Boston Health Care System, Boston University School of Medicine, Boston, Massachusetts, USA.
Clin Infect Dis. 2011 Mar 1;52(5):e103-20. doi: 10.1093/cid/ciq257.
A Panel of International Experts was convened by the Infectious Diseases Society of America (IDSA) in collaboration with the European Society for Microbiology and Infectious Diseases (ESCMID) to update the 1999 Uncomplicated Urinary Tract Infection Guidelines by the IDSA. Co-sponsoring organizations include the American Congress of Obstetricians and Gynecologists, American Urological Association, Association of Medical Microbiology and Infectious Diseases-Canada, and the Society for Academic Emergency Medicine. The focus of this work is treatment of women with acute uncomplicated cystitis and pyelonephritis, diagnoses limited in these guidelines to premenopausal, non-pregnant women with no known urological abnormalities or co-morbidities. The issues of in vitro resistance prevalence and the ecological adverse effects of antimicrobial therapy (collateral damage) were considered as important factors in making optimal treatment choices and thus are reflected in the rankings of recommendations.
美国传染病学会（IDSA）与欧洲临床微生物学和传染病学会（ESCMID）合作，召集了一组国际专家，对 IDSA 于 1999 年发布的《非复杂性尿路感染治疗指南》进行更新。共同发起的组织包括美国妇产科医师学会、美国泌尿外科学会、加拿大医学微生物学和传染病协会，以及学术急救医学协会。这项工作的重点是治疗患有急性单纯性膀胱炎和肾盂肾炎的女性，这些指南的诊断仅限于绝经前、无已知泌尿系统异常或合并症的非妊娠女性。体外耐药率和抗菌治疗的生态不良影响（附带损害）被认为是做出最佳治疗选择的重要因素，因此反映在推荐等级中。
